메뉴 건너뛰기
Nephrology Dialysis Transplantation
Volumn 13, Issue SUPPL. 7, 1998, Pages 30-32
Renal impairment in myeloma: Time for a reappraisal?
Author keywords

[No Author keywords available]
Indexed keywords

CREATININE;
EID: 0031784520     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_7.30     Document Type: Conference Paper
Times cited : (7)
References (10)
  • 1
    • 0020056959 scopus 로고
    • Monoclonal gammopathies in the adult population of Finistere, France
    • Saleun JP, Vicariot M, Deroff P, Morin JF. Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol 1982; 35; 63-68
    • (1982) J Clin Pathol , vol.35 , pp. 63-68
    • Saleun, J.P.1    Vicariot, M.2    Deroff, P.3    Morin, J.F.4
  • 2
    • 0023511385 scopus 로고
    • Monoclonal gammopathy and multiple myeloma in the elderly
    • Kyle RA. Monoclonal gammopathy and multiple myeloma in the elderly. Clin Haematol 1987; 1: 533-557
    • (1987) Clin Haematol , vol.1 , pp. 533-557
    • Kyle, R.A.1
  • 3
    • 7844228151 scopus 로고
    • The prognostic significance of serum beta-2 microglobulin compared with other presentation features in myelomatosis
    • Cuzick J, Cooper EH, MacLennan, ICM. The prognostic significance of serum beta-2 microglobulin compared with other presentation features in myelomatosis. Br J Cancer 1985; 288: 1411 1416
    • (1985) Br J Cancer , vol.288 , pp. 1411-1416
    • Cuzick, J.1    Cooper, E.H.2    MacLennan, I.C.M.3
  • 4
    • 0028952405 scopus 로고
    • Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma
    • Pelliniemi TT, Irjala K, Mattila K et al. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Blood 1995; 85: 765-771
    • (1995) Blood , vol.85 , pp. 765-771
    • Pelliniemi, T.T.1    Irjala, K.2    Mattila, K.3
  • 5
    • 0019157152 scopus 로고
    • Prognostic features in the third MRC myelomatosis trial
    • MRC Working Party. Prognostic features in the third MRC myelomatosis trial. Br J Cancer 1980; 42: 831-840
    • (1980) Br J Cancer , vol.42 , pp. 831-840
  • 6
    • 0016804136 scopus 로고
    • A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
    • Durie BGM, Salmon, SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842 854
    • (1975) Cancer , vol.36 , pp. 842-854
    • Durie, B.G.M.1    Salmon, S.E.2
  • 7
    • 0021206338 scopus 로고
    • Analysis and management of renal failure in fourth MRC myelomatosis trial
    • MRC Working Party. Analysis and management of renal failure in fourth MRC myelomatosis trial. Br Med J 1984; 288: 1411-1416
    • (1984) Br Med J , vol.288 , pp. 1411-1416
  • 8
    • 0025294041 scopus 로고
    • Renal failure in myeloma. Pathogenesis and prognostic implications
    • Alexanian R, Barlogic B, Dixon D. Renal failure in myeloma. Pathogenesis and prognostic implications. Arch Intern Med 1990; 150: 1693 1695
    • (1990) Arch Intern Med , vol.150 , pp. 1693-1695
    • Alexanian, R.1    Barlogic, B.2    Dixon, D.3
  • 10
    • 0027983610 scopus 로고
    • Acute renal failure in myeloma
    • Mallick NP. Acute renal failure in myeloma. Nephrol Dial Transplant 1994; 9 [Suppl 4]: 108 110
    • (1994) Nephrol Dial Transplant , vol.9 , Issue.4 SUPPL. , pp. 108-110
    • Mallick, N.P.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.